{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:50:22Z","timestamp":1777301422499,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["120Z942"],"award-info":[{"award-number":["120Z942"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018847","name":"Sel\u00e7uk University Research Foundation","doi-asserted-by":"publisher","award":["21401070"],"award-info":[{"award-number":["21401070"]}],"id":[{"id":"10.13039\/501100018847","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Selcuk University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide, underscoring the urgent need for novel and effective therapeutic agents. Conventional treatments, including chemotherapy, radiotherapy, and surgery, are often associated with significant adverse effects, prompting the exploration of alternative therapeutic strategies. This study aimed to evaluate the anticancer effects of\n                    <jats:italic>Scorpio fuscus<\/jats:italic>\n                    venom (\n                    <jats:italic>SFV<\/jats:italic>\n                    ) on human colorectal cancer models using integrated in vitro and in vivo approaches.\n                    <jats:italic>SFV<\/jats:italic>\n                    constituents were characterized using gel electrophoresis, followed by high-performance liquid chromatography and UV\u2013visible spectrometry. Identified peptides were subjected to structural modeling and in silico docking analyses against selected proteins associated with colorectal cancer and apoptosis-related pathways. The cytotoxic effects of\n                    <jats:italic>SFV<\/jats:italic>\n                    were assessed in human CRC cell lines (DLD-1, HT-29, and CaCo-2) and a healthy colon epithelial cell line (CCD-18Co) using Alamar Blue assays after 48-h treatment, and half-maximal inhibitory concentration (IC\u2085\u2080) values were determined.\n                    <jats:italic>SFV<\/jats:italic>\n                    treatment resulted in a dose-dependent reduction in cancer cell viability, accompanied by decreased migratory capacity and colony formation ability. Apoptotic responses were further evaluated by flow cytometry and gene expression analyses, indicating modulation of apoptosis-associated genes. For in vivo validation, subcutaneous and orthotopic xenograft colon cancer models were established in mice.\n                    <jats:italic>SFV<\/jats:italic>\n                    administration led to reduced tumor growth compared with control groups. Immunohistochemical analyses revealed altered expression patterns of selected tumor-related markers in\n                    <jats:italic>SFV<\/jats:italic>\n                    -treated tumors. Gene expression profiling demonstrated\u2009\u2265\u2009twofold changes in 51 genes, including downregulation of BAK1 and TRAF3, and upregulation of BIRC2, BIRC3, BIRC6, CASP8, TNFRSF8, TNFRSF11, and BOK. Collectively, these findings indicate that\n                    <jats:italic>SFV<\/jats:italic>\n                    exerts significant antitumor effects in colorectal cancer models and support its potential as a promising anticancer agent, warranting further mechanistic and translational investigation.\n                  <\/jats:p>","DOI":"10.1007\/s10637-026-01598-z","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T05:59:25Z","timestamp":1770011965000},"page":"23-38","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Scorpio fuscus venom as a promising anticancer agent against colorectal cancer"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4449-6103","authenticated-orcid":false,"given":"Serdar","family":"Karakurt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3538-6551","authenticated-orcid":false,"given":"Cigdem","family":"Gokcek-Sarac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8404-7994","authenticated-orcid":false,"given":"Sinan","family":"Kandir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3162-8381","authenticated-orcid":false,"given":"Irem Mukaddes","family":"Bilgiseven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0396-3975","authenticated-orcid":false,"given":"Ersen Ayd\u0131n","family":"Yagmur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7207-2730","authenticated-orcid":false,"given":"Hasan Ufuk","family":"Celebioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"issue":"15","key":"1598_CR1","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.3390\/cancers13153817","volume":"13","author":"C Himbert","year":"2021","unstructured":"Himbert C, Figueiredo JC, Shibata D, Ose J, Lin T, Huang LC, Peoples AR, Scaife CL, Pickron B, Lambert L, Cohan JN, Bronner M, Felder S, Sanchez J, Dessureault S, Coppola D, Hoffman DM, Nasseri YF, Decker RW, Zaghiyan K, Murrell ZA, Hendifar A, Gong J, Firoozmand E, Gangi A, Moore BA, Cologne KG, El-Masry MS, Hinkle N, Monroe J, Mutch M, Bernadt C, Chatterjee D, Sinanan M, Cohen SA, Wallin U, Grady WM, Lampe PD, Reddi D, Krane M, Fichera A, Moonka R, Herpel E, Schirmacher P, Kloor M, von Knebel-Doeberitz M, Nattenmueller J, Kauczor HU, Swanson E, Jedrzkiewicz J, Schmit SL, Gigic B, Ulrich AB, Toriola AT, Siegel EM, Li CI, Ulrich CM, Hardikar S (2021) Clinical characteristics and outcomes of colorectal cancer in the colocare study: differences by age of onset. Cancers 13(15):3817","journal-title":"Cancers"},{"issue":"9","key":"1598_CR2","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3390\/cancers13092025","volume":"13","author":"T Sawicki","year":"2021","unstructured":"Sawicki T, Ruszkowska M, Danielewicz A, Niedzwiedzka E, Arlukowicz T, Przybylowicz KE (2021) A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers (Basel) 13(9):2025","journal-title":"Cancers (Basel)"},{"key":"1598_CR3","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/sj.bjc.6602783","volume":"93","author":"B Schuell","year":"2005","unstructured":"Schuell B, Gruenberger T, Kornek GV, Dworan N, Depisch D, Lang F, Schneeweiss B, Scheithauer W (2005) Side effects during chemotherapy predict tumour response in advanced colorectal cancer. Br J Cancer 93:744","journal-title":"Br J Cancer"},{"key":"1598_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s13046-021-02130-2","volume":"40","author":"J Zhou","year":"2021","unstructured":"Zhou J, Ji Q, Li Q (2021) Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies. J Exp Clin Cancer Res 40:328","journal-title":"J Exp Clin Cancer Res"},{"key":"1598_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4240\/wjgs.v15.i4.495","volume":"15","author":"A Kumar","year":"2023","unstructured":"Kumar A, Gautam V, Sandhu A, Rawat K, Sharma A, Saha L (2023) Current and emerging therapeutic approaches for colorectal cancer: a comprehensive review. World J Gastrointest Surg 15:495","journal-title":"World J Gastrointest Surg"},{"key":"1598_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/0115665232273077240104045022","volume":"24","author":"S Sriramulu","year":"2024","unstructured":"Sriramulu S, Malayaperumal S, Banerjee A, Anbalagan M, Kumar MM, Radha RKN, Liu X, Zhang H, Hu G, Sun XF, Pathak S (2024) AEG-1 as a novel therapeutic target in colon cancer: a study fromsilencing AEG-1 in BALB\/c mice to large data analysis. Curr Gene Ther 24:307","journal-title":"Curr Gene Ther"},{"key":"1598_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2174\/0115665232325395241018103006","volume":"25","author":"S Wang","year":"2025","unstructured":"Wang S, Zhang L, Li D, Gou M (2025) Comprehensive analysis and experimental validation of HEPACAM2as a potential prognosis biomarker and immunotherapy target incolorectal cancer. Curr Gene Ther 25:518","journal-title":"Curr Gene Ther"},{"key":"1598_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.2174\/0115665232294568240201073417","volume":"24","author":"T Jiang","year":"2024","unstructured":"Jiang T, Zheng J, Li N, Li X, He J, Zhou J, Sun B, Chi Q (2024) <article-title update=\"added\">Dissecting the mechanisms of intestinal immune homeostasis byanalyzing T-cell immune response in Crohn\u2019s disease and colorectalcancer. Curr Gene Ther 24:422","journal-title":"Curr Gene Ther"},{"key":"1598_CR9","doi-asserted-by":"crossref","unstructured":"Tian S, Chen M, Jing W, Meng Q, Wu J (2024)  miR-1204 positioning in 8q24.21 involved in the tumorigenesis of colorectal cancer by targeting MASPIN. Protein & Peptide Lett 31:544","DOI":"10.2174\/0109298665305114240718072029"},{"key":"1598_CR10","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429283717231222104730","volume":"17","author":"M Li","year":"2024","unstructured":"Li M, Fan J, Hu M, Xu J, He Z, Zeng J (2024) Quercetin enhances 5-fluorouracil sensitivity by regulating the autophagicflux and inducing Drp-1 mediated mitochondrial fragmentation in colorectalcancer cells. Curr Mol Pharmacol 17:e18761429283717","journal-title":"Curr Mol Pharmacol"},{"key":"1598_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/0113892029312303240821080358","volume":"26","author":"J Liu","year":"2025","unstructured":"Liu J, Qiu S, Fu X, Zhou B, Zu R, Lv Z, Li Y, Yang L, Zhou Z (2025) Transcriptomic landscape of colorectal mucinous adenocarcinoma has similarity with intestinal goblet cell differentiation. Curr Genomics 26:95","journal-title":"Curr Genomics"},{"key":"1598_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/srep14973","volume":"5","author":"S Zhang","year":"2015","unstructured":"Zhang S, Gao B, Zhu S (2015) Target-driven evolution of scorpion toxins. Sci Rep 5:14973","journal-title":"Sci Rep"},{"key":"1598_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ympev.2015.04.028","volume":"91","author":"S Talal","year":"2015","unstructured":"Talal S, Tesler I, Sivan J, Ben-Shlomo R, Muhammad Tahir H, Prendini L, Snir S, Gefen E (2015) Scorpion speciation in the Holy Land: multilocus phylogeography corroborates diagnostic differences in morphology and burrowing behavior among Scorpio subspecies and justifies recognition as phylogenetic, ecological and biological species. Mol Phylogenet Evol 91:226","journal-title":"Mol Phylogenet Evol"},{"key":"1598_CR14","unstructured":"Abu Afifeh B, Ya\u011fmur EA, Al-Saraireh M, Amr Z (2024) Revision of the genus Scorpio in Jordan, with a description of a new genus and three new species (Scorpiones: Scorpionidae). Euscorpius 391:1"},{"issue":"12","key":"1598_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/toxins9120399","volume":"9","author":"T Romero-Gutierrez","year":"2017","unstructured":"Romero-Gutierrez T, Peguero-Sanchez E, Cevallos MA, Batista CVF, Ortiz E, Possani LD (2017) A deeper examination of Thorellius atrox scorpion venom components with omic technologies. Toxins (Basel) 9(12):399. https:\/\/doi.org\/10.3390\/toxins9120399","journal-title":"Toxins (Basel)"},{"key":"1598_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.toxicon.2016.05.002","volume":"118","author":"HL Gomes","year":"2016","unstructured":"Gomes HL, Menezes TN, Malacarne PF, Roman-Campos D, Gondim AN, Cruz JS, Vassallo DV, Figueiredo SG (2016) Cardiovascular effects of Sp-CTx, a cytolysin from the scorpionfish (Scorpaena plumieri) venom. Toxicon 118:141","journal-title":"Toxicon"},{"key":"1598_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0896-6273(95)90057-8","volume":"15","author":"C Miller","year":"1995","unstructured":"Miller C (1995) The charybdotoxin family of K+ channel-blocking peptides. Neuron 15:5","journal-title":"Neuron"},{"issue":"8","key":"1598_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/toxins17080411","volume":"17","author":"KCF Bordon","year":"2025","unstructured":"Bordon KCF, Santos GC, Martins JG, Wiezel GA, Amorim FG, Crasset T, Redureau D, Quinton L, Procopio REL, Arantes EC (2025) Pioneering comparative proteomic and enzymatic profiling of Amazonian scorpion venoms enables the isolation of their first \u03b1-Ktx, metalloprotease, and phospholipase A2. Toxins (Basel) 17(8):411. https:\/\/doi.org\/10.3390\/toxins17080411","journal-title":"Toxins (Basel)"},{"issue":"21","key":"1598_CR19","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.3390\/molecules29215080","volume":"29","author":"Z Xia","year":"2024","unstructured":"Xia Z, Xie L, Li B, Lv X, Zhang H, Cao Z (2024) Antimicrobial potential of scorpion-venom-derived peptides. Molecules 29(21):5080. https:\/\/doi.org\/10.3390\/molecules29215080","journal-title":"Molecules"},{"key":"1598_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12050326","author":"RA Duenas-Cuellar","year":"2020","unstructured":"Duenas-Cuellar RA, Santana CJC, Magalhaes ACM, Pires OR Jr., Fontes W, Castro MS (2020) Scorpion toxins and ion channels: potential applications in cancer therapy. Toxins (Basel)12(5):326.\u00a0https:\/\/doi.org\/10.3390\/toxins12050326","journal-title":"Toxins (Basel)"},{"issue":"12","key":"1598_CR21","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/toxins8120348","volume":"8","author":"D Cajado-Carvalho","year":"2016","unstructured":"Cajado-Carvalho D, Kuniyoshi AK, Duzzi B, Iwai LK, Oliveira UC, Junqueira de Azevedo IL, Kodama RT, Portaro FV (2016) Insights into the hypertensive effects of tityus serrulatus scorpion venom: purification of an angiotensin-converting enzyme-like peptidase. Toxins (Basel) 8(12):348","journal-title":"Toxins (Basel)"},{"key":"1598_CR22","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.toxicon.2005.09.006","volume":"46","author":"RC Rodriguez de la Vega","year":"2005","unstructured":"Rodriguez de la Vega RC, Possani LD (2005) Overview of scorpion toxins specific for Na+ channels and related peptides: biodiversity, structure-function relationships and evolution. Toxicon 46(8):831","journal-title":"Toxicon"},{"key":"1598_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep44685","volume":"7","author":"C Giovannini","year":"2017","unstructured":"Giovannini C, Baglioni M, Baron Toaldo M, Cescon M, Bolondi L, Gramantieri L (2017) Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma. Sci Rep 7:44685","journal-title":"Sci Rep"},{"key":"1598_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jprot.2014.04.032","volume":"106","author":"X Xu","year":"2014","unstructured":"Xu X, Duan Z, Di Z, He Y, Li J, Li Z, Xie C, Zeng X, Cao Z, Wu Y, Liang S, Li W (2014) Proteomic analysis of the venom from the scorpion Mesobuthus martensii. J Proteomics 106:162","journal-title":"J Proteomics"},{"key":"1598_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2025.108506","volume":"265","author":"HU Celebioglu","year":"2025","unstructured":"Celebioglu HU, Kandir S, Gokcek-Sarac C, Yagmur EA, Svensson B, Karakurt S (2025) Proteomic characterization of venom from Scorpio fuscus (Scorpiones: Scorpionidae) with perspectives for therapeutic applications. Toxicon 265:108506","journal-title":"Toxicon"},{"key":"1598_CR26","volume":"4","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Wurbel H (2020) BMJ Open Sci 4:e100115","journal-title":"BMJ Open Sci"},{"key":"1598_CR27","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1177\/026119299902700609","volume":"27","author":"H Spielmann","year":"1999","unstructured":"Spielmann H, Genschow E, Liebsch M, Halle W (1999) Determination of the starting dose for acute oral toxicity (LD50) testing in the up and down procedure (UDP) from cytotoxicity data. Altern Lab Anim 27:957","journal-title":"Altern Lab Anim"},{"key":"1598_CR28","first-page":"1","volume":"7","author":"N Iccvam","year":"2006","unstructured":"Iccvam N (2006) In vitro cytotoxicity test methods for estimating starting doses for acute oral systemic toxicity testing NIH Publ 7:1","journal-title":"NIH Publ"},{"key":"1598_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/(SICI)1097-0096(199611\/12)24:9<501::AID-JCU2>3.0.CO;2-R","volume":"24","author":"GJ Matthews","year":"1996","unstructured":"Matthews GJ, Motta J, Fracehia JA (1996) The accuracy of transrectal ultrasound prostate volume estimation: clinical correlations. J\u00a0Clin Ultrasound 24(9):501","journal-title":"J Clin Ultrasound"},{"issue":"1","key":"1598_CR30","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics 2025. CA Cancer J Clin 75(1):10","journal-title":"CA Cancer J Clin"},{"key":"1598_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.toxicon.2017.02.007","volume":"130","author":"S Estrada-Gomez","year":"2017","unstructured":"Estrada-Gomez S, Gomez-Rave L, Vargas-Munoz LJ, van der Meijden A (2017) Characterizing the biological and biochemical profile of six different scorpion venoms from the Buthidae and Scorpionidae family. Toxicon 130:104","journal-title":"Toxicon"},{"key":"1598_CR32","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1134\/S0006297915130118","volume":"80","author":"AI Kuzmenkov","year":"2015","unstructured":"Kuzmenkov AI, Grishin EV, Vassilevski AA (2015) Diversity of potassium channel ligands: focus on scorpion toxins. Biochemistry (Mosc) 80:1764","journal-title":"Biochemistry (Mosc)"},{"key":"1598_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1678-9199-19-5","volume":"19","author":"N Oukkache","year":"2013","unstructured":"Oukkache N, Chgoury F, Lalaoui M, Cano AA, Ghalim N (2013) Comparison between two methods of scorpion venom milking in Morocco. J Venom Anim Toxins Incl Trop Dis 19:5","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"1598_CR34","doi-asserted-by":"publisher","first-page":"14025","DOI":"10.1021\/acs.analchem.1c02804","volume":"93","author":"F Chen","year":"2021","unstructured":"Chen F, Qin M, Liu W, Wang F, Ren W, Xu H, Li F (2021) Snake venom identification via fluorescent discrimination. Anal Chem 93:14025","journal-title":"Anal Chem"},{"key":"1598_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009659","volume":"15","author":"N Alomran","year":"2021","unstructured":"Alomran N, Alsolaiss J, Albulescu LO, Crittenden E, Harrison RA, Ainsworth S, Casewell NR (2021) Pathology-specific experimental antivenoms for haemotoxic snakebite: the impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms. PLoS Negl Trop Dis 15:e0009659","journal-title":"PLoS Negl Trop Dis"},{"key":"1598_CR36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.toxicon.2013.07.012","volume":"76","author":"V Quintero-Hernandez","year":"2013","unstructured":"Quintero-Hernandez V, Jimenez-Vargas JM, Gurrola GB, Valdivia HH, Possani LD (2013) Scorpion venom components that affect ion-channels function. Toxicon 76:328","journal-title":"Toxicon"},{"key":"1598_CR37","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0041-0101(99)00197-X","volume":"38","author":"SS Veiga","year":"2000","unstructured":"Veiga SS, da Silveira RB, Dreyfus JL, Haoach J, Pereira AM, Mangili OC, Gremski W (2000)\u00a0Identification of high molecular weight serine-proteases in Loxosceles intermedia (brown spider) venom. Toxicon 38:825","journal-title":"Toxicon"},{"key":"1598_CR38","first-page":"11","volume":"6","author":"A Diaz-Garcia","year":"2015","unstructured":"Diaz-Garcia A, Ruiz-Fuentes JL, Yglesias-Rivera A, Rodriguez-Sanchez H, Riquenes Garlobo Y, Fleitas Martinez O, Fraga Castro JA (2015) Enzymatic analysis of venom from Cuban scorpion Rhopalurus junceus. J Venom Res 6:11","journal-title":"J Venom Res"},{"key":"1598_CR39","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cdp.2006.06.002","volume":"30","author":"A Felipe","year":"2006","unstructured":"Felipe A, Vicente R, Villalonga N, Roura-Ferrer M, Martinez-Marmol R, Sole L, Ferreres JC, Condom E (2006) Potassium channels: new targets in cancer therapy. Cancer Detect Prev 30:375","journal-title":"Cancer Detect Prev"},{"key":"1598_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-8-113","volume":"8","author":"V Asher","year":"2010","unstructured":"Asher V, Sowter H, Shaw R, Bali A, Khan R (2010) Eag and HERG potassium channels as novel therapeutic targets in cancer. World J Surg Oncol 8:113","journal-title":"World J Surg Oncol"},{"key":"1598_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.toxicon.2015.08.022","volume":"105","author":"I Jridi","year":"2015","unstructured":"Jridi I, Catacchio I, Majdoub H, Shahbazeddah D, El Ayeb M, Frassanito MA, Ribatti D, Vacca A, Borchani L (2015) Hemilipin, a novel Hemiscorpius lepturus venom heterodimeric phospholipase A2, which inhibits angiogenesis in\u00a0vitro and in\u00a0vivo. Toxicon 105:34","journal-title":"Toxicon"},{"key":"1598_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ijbiomac.2018.04.141","volume":"116","author":"N Krayem","year":"2018","unstructured":"Krayem N, Abdelkefi-Koubaa Z, Marrakchi N, Gargouri Y, Luis J (2018) Native and recombinant phospholipases A2 of Scorpio maurus venom glands impair angiogenesis by targeting integrins \u03b15\u03b21 and \u03b1v\u03b23. Int J Biol Macromol 116:305","journal-title":"Int J Biol Macromol"},{"key":"1598_CR43","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.biopha.2016.10.041","volume":"84","author":"S Satitmanwiwat","year":"2016","unstructured":"Satitmanwiwat S, Changsangfa C, Khanuengthong A, Promthep K, Roytrakul S, Arpornsuwan T, Saikhun K, Sritanaudomchai H (2016) The scorpion venom peptide BmKn2 induces apoptosis in cancerous but not in normal human oral cells. Biomed Pharmacother 84:1042","journal-title":"Biomed Pharmacother"},{"key":"1598_CR44","first-page":"233","volume":"3","author":"C Raposo","year":"2017","unstructured":"Raposo C (2017) Scorpion and spider venoms in cancer treatment: state of the art, challenges, and perspectives. J\u00a0Clin Transl Res 3:233","journal-title":"J Clin Transl Res"},{"key":"1598_CR45","first-page":"5","volume":"4","author":"A Diaz-Garcia","year":"2013","unstructured":"Diaz-Garcia A, Morier-Diaz L, Frion-Herrera Y, Rodriguez-Sanchez H, Caballero-Lorenzo Y, Mendoza-Llanes D, Riquenes-Garlobo Y, Fraga-Castro JA (2013) In vitro anticancer effect of venom from Cuban scorpion Rhopalurus junceus against a panel of human cancer cell lines. J\u00a0Venom Res 4:5","journal-title":"J Venom Res"},{"key":"1598_CR46","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3892\/ol.2015.4036","volume":"11","author":"AK Al-Asmari","year":"2016","unstructured":"Al-Asmari AK, Islam M, Al-Zahrani AM (2016) In vitro analysis of the anticancer properties of scorpion venom in colorectal and breast cancer cell lines. Oncol Lett 11:1256","journal-title":"Oncol Lett"},{"key":"1598_CR47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12032-025-02689-2","volume":"42","author":"HN Canak","year":"2025","unstructured":"Canak HN, Bas K, Yagmur EA, Karakurt S (2025)\u00a0Mesobuthus eupeus venom modulates colorectal carcinoma signaling pathways and induces apoptosis. Med Oncol 42:163","journal-title":"Med Oncol"},{"key":"1598_CR48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4251\/wjgo.v10.i9.244","volume":"10","author":"AK Pandurangan","year":"2018","unstructured":"Pandurangan AK, Divya T, Kumar K, Dineshbabu V, Velavan B, Sudhandiran G (2018)\u00a0Colorectal carcinogenesis: Insights into the cell death and signal transduction pathways: A review.\u00a0 Pandurangan AK, Divya T, Kumar K, Dineshbabu V, Velavan B, Sudhandiran G.\u00a0Colorectal carcinogenesis: Insights into the cell death and signal transduction pathways: A review.\u00a0\u00a0World J Gastrointest Oncol 10:244","journal-title":"World J Gastrointest Oncol"},{"key":"1598_CR49","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/cdd.2013.10","volume":"20","author":"N Echeverry","year":"2013","unstructured":"Echeverry N, Bachmann D, Ke F, Strasser A, Simon HU, Kaufmann T (2013) Intracellular localization of the BCL-2 family member BOK and functional implications. Cell Death Differ 20:785","journal-title":"Cell Death Differ"},{"key":"1598_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174363","author":"CM Neophytou","year":"2021","unstructured":"Neophytou CM, Trougakos IP, Erin N, Papageorgis P (2021) Apoptosis deregulation and the development of cancer multi-drug resistance. Cancers (Basel) 13(17):4363.\u00a0https:\/\/doi.org\/10.3390\/cancers13174363","journal-title":"Cancers (Basel)"},{"key":"1598_CR51","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10565-018-09455-3","volume":"35","author":"M Moradi","year":"2019","unstructured":"Moradi M, Najafi R, Amini R, Solgi R, Tanzadehpanah H, Esfahani AM, Saidijam M (2019) Remarkable apoptotic pathway of Hemiscorpius lepturus scorpion venom on CT26 cell line. Cell Biol Toxicol 35:373","journal-title":"Cell Biol Toxicol"},{"key":"1598_CR52","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1534735417704949","volume":"17","author":"AK Al-Asmari","year":"2018","unstructured":"Al-Asmari AK, Riyasdeen A, Islam M (2018) Scorpion venom causes upregulation of p53 and downregulation of Bcl-x L and bid protein expression by modulating signaling proteins Erk 1\/2 and STAT3, and DNA damage in breast and colorectal cancer cell lines. Integr Cancer Ther 17:271","journal-title":"Integr Cancer Ther"},{"key":"1598_CR53","doi-asserted-by":"publisher","DOI":"10.1177\/2156587217751796","volume":"23","author":"AK Al-Asmari","year":"2018","unstructured":"Al-Asmari AK, Riyasdeen A, Islam M (2018) Scorpion venom causes apoptosis by increasing reactive oxygen species and cell cycle arrest in MDA-MB-231 and HCT-8 cancer cell lines. J Evid Based Integr Med 23:2156587217751796","journal-title":"J Evid Based Integr Med"},{"key":"1598_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-016-9797-7","volume":"33","author":"D Bettenworth","year":"2016","unstructured":"Bettenworth D, Mucke MM, Schwegmann K, Faust A, Poremba C, Schafers M, Domagk D, Lenz P (2016) Endoscopy-guided orthotopic implantation of colorectal cancer cells results in metastatic colorectal cancer in mice. Clin Exp Metastasis 33:551","journal-title":"Clin Exp Metastasis"},{"key":"1598_CR55","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232654","volume":"312","author":"RA Sheth","year":"2024","unstructured":"Sheth RA, Wehrenberg-Klee E, Patel SP, Brock KK, Fotiadis N, de Baere T (2024) Intratumoral injection of immunotherapeutics: state of the art and future directions. Radiology 312:e232654","journal-title":"Radiology"},{"key":"1598_CR56","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.canlet.2009.10.011","volume":"291","author":"S Fan","year":"2010","unstructured":"Fan S, Sun Z, Jiang D, Dai C, Ma Y, Zhao Z, Liu H, Wu Y, Cao Z, Li W (2010) BmKCT toxin inhibits glioma proliferation and tumor metastasis. Cancer Lett 291:158","journal-title":"Cancer Lett"},{"key":"1598_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-016-2269-3","volume":"5","author":"ML Salem","year":"2016","unstructured":"Salem ML, Shoukry NM, Teleb WK, Abdel-Daim MM, Abdel-Rahman MA (2016) In vitro and in vivo antitumor effects of the Egyptian scorpion Androctonus amoreuxi venom in an Ehrlich ascites tumor model. Springerplus 5:570","journal-title":"Springerplus"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-026-01598-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-026-01598-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-026-01598-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:03:06Z","timestamp":1777298586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-026-01598-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1598"],"URL":"https:\/\/doi.org\/10.1007\/s10637-026-01598-z","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}